Holen Sie sich die Stockscreener-App
5.04
1.41%
0.07
Handel nachbörslich:
4.75
-0.29
-5.75%
Schlusskurs vom Vortag:
$4.97
Offen:
$5.01
24-Stunden-Volumen:
399.37K
Relative Volume:
0.42
Marktkapitalisierung:
$91.49M
Einnahmen:
$114.73M
Nettoeinkommen (Verlust:
$-140.94M
KGV:
-1.8261
EPS:
-2.76
Netto-Cashflow:
$-126.18M
1W Leistung:
-11.27%
1M Leistung:
+36.22%
6M Leistung:
-66.49%
1J Leistung:
-58.26%
1-Tages-Spanne:
$4.70
$5.10
1-Wochen-Bereich:
$4.70
$5.76
52-Wochen-Spanne:
$3.10
$21.98
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Vergleichen Sie OM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
5.04 | 90.22M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
109.02 | 190.25B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
360.82 | 140.79B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
BSX
Boston Scientific Corp
|
91.62 | 136.25B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
103.18 | 131.68B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
82.10 | 47.96B | 5.88B | 1.34B | 799.60M | 2.3489 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical, Inc. (NASDAQ:OM) Held Back By Insufficient Growth Even After Shares Climb 35% - simplywall.st
Is Outset Medical Inc benefiting from innovation trendsJuly 2025 Retail & Expert Approved Momentum Ideas - baoquankhu1.vn
Outset Medical (NASDAQ:OM) Rating Increased to Hold at Wall Street Zen - MarketBeat
What are the future prospects of Outset Medical Inc.Weekly Earnings Recap & Reliable Momentum Entry Alerts - Mfd.ru
Outset Medical, Inc. (OM) Investor Outlook: Is A 133.83% Upside On The Horizon? - DirectorsTalk Interviews
OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - Finviz
Quarterly Earnings: What is Outset Medical Incs 5 year growth outlookMarket Activity Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Guidance Update: Is Outset Medical Inc being accumulated by smart moneyJuly 2025 Volume & Long-Term Safe Investment Plans - baoquankhu1.vn
Outset Medical secures FDA clearance for Tablo haemodialysis system - Yahoo Finance
Is Outset Medical Inc. stock risky to hold nowQuarterly Portfolio Report & Long-Term Growth Stock Strategies - Mfd.ru
Outset Medical Gets FDA Clearance for Tablo Hemodialysis System - marketscreener.com
Outset Medical wins FDA nod for next-gen Tablo hemodialysis system - MassDevice
Outset Medical, Inc. Announces 510(K) Clearance by the U.S. Food and Drug Administration of Its Next-Generation Tablo Platform - marketscreener.com
Outset Medical Secures FDA Clearance For Next-Generation Tablo Hemodialysis System - Nasdaq
Outset Medical (OM) Gains FDA Clearance for Advanced Tablo Platf - GuruFocus
Outset Medical’s Tablo dialysis system meets FDA cybersecurity standards - Investing.com
Outset Medical Wins FDA Clearance for Next-Gen Tablo System - TipRanks
Outset Medical stock jumps after FDA clears next-gen Tablo platform By Investing.com - Investing.com Australia
Outset Medical stock jumps after FDA clears next-gen Tablo platform - Investing.com Nigeria
Outset Medical rises after FDA clears upgraded dialysis system - TradingView
Outset Medical, Inc. Announces FDA Clearance for Next-Gen Tablo Platform - TradingView
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned - The Manila Times
Outset Medical receives FDA clearance for next-generation Tablo dialysis system - StreetInsider
Outset Medical, Inc. to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 11, 2026 - Quiver Quantitative
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 - The Manila Times
Dialysis device maker Outset Medical sets Feb. 11 results call - stocktitan.net
Will Outset Medical Inc benefit from geopolitical trends2025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Earnings Beat: Is Outset Medical Inc stock risky to hold now2025 Price Momentum & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Don't Ignore The Insider Selling In Outset Medical - Sahm
Aug Levels: Will Outset Medical Inc face regulatory challenges2025 Technical Patterns & Weekly Stock Performance Updates - baoquankhu1.vn
Outset Medical, Inc. (OM): Investor Outlook With A Promising 125.96% Potential Upside - DirectorsTalk Interviews
Outset Medical chair and CEO Trigg sells $71k in stock - Investing.com India
Outset Medical chair and CEO Trigg sells $71k in stock By Investing.com - Investing.com India
Outset Medical (NASDAQ:OM) EVP Marc Nash Sells 5,375 Shares - MarketBeat
Outset Medical (NASDAQ:OM) General Counsel Sells $47,687.68 in Stock - MarketBeat
Leslie Trigg Sells 2,120 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Insider Selling: Outset Medical (NASDAQ:OM) CEO Sells 11,794 Shares of Stock - MarketBeat
Will Outset Medical Inc. benefit from geopolitical trendsQuarterly Trade Summary & AI Enhanced Execution Alerts - bollywoodhelpline.com
Aug Opening: What is Outset Medical Incs 5 year growth outlookWall Street Watch & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Outset Medical (OM) soars 22.2%: Is further upside left in the stock? - MSN
Published on: 2026-01-14 00:30:41 - Bộ Nội Vụ
San Jose-based Outset Medical revenue up 5% to USD 119.5M in FY 2025 - Medical Buyer
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? - Yahoo Finance
Outset Medical reports 5% revenue growth in 2025, names new director - Investing.com Nigeria
Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance By Investing.com - Investing.com South Africa
Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance - Investing.com Australia
Outset Medical Gears Up for J.P. Morgan Healthcare Conference Buckle Up for Exciting Updates! - StocksToTrade
Stifel on Outset Medical Inc. (OM): 'Overall Solid 2025 Finish As Preliminary 4Q25 Sales Beat Consensus' - StreetInsider
Outset Medical reports 5% revenue growth in 2025, names new director By Investing.com - Investing.com South Africa
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):